New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process

By LabMedica International staff writers
Posted on 06 Dec 2022

Tianlong Science and Technology (Shaanxi, China) is all set to launch its new all-in-one molecular diagnostic system in the first quarter of 2023.

Tianlong’s all-new Panall 8000 molecular diagnostic system will arrive in the market in the first quarter of 2023. The Panall 8000 is a simple and secure all-in-one molecular diagnostic system that integrates the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection and result analysis. This can help realize a true sample in -result out detection process and bring great convenience for professionals with only one-key operation.

Image: The Panall 8000 molecular diagnostic system will be launched in the first quarter of 2023 (Photo courtesy of Tianlong)

The Panall 8000 offers fewer steps, walkaway workflow and high quality results. Its closed system minimizes contamination, and it allows eight samples to be inserted at the same time. It does not require any additional equipment or interpretation of results. Tianlong will be offering a testing menu for respiratory infections to be run on the Panall 8000 that will enable the detection of 17 types of respiratory pathogens, including Flu A, Flu B, RSV and SARS-CoV-2, among others.

Related Links:
Tianlong Science and Technology